NUCANA
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry technology to transform some of the most widely prescribed chemotherapy agents into more effective and safer medicines.
NUCANA
Social Links:
Industry:
Clinical Trials
Founded:
2008-01-01
Address:
Edinburgh, Edinburgh, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.nucana.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0)131 357 1111
Email Addresses:
[email protected]
Total Funding:
67.4 M USD
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Humanetics Corporation
clinical stage pharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Investors List
Alida Capital International
Alida Capital International investment in Series B - NuCana
Sofinnova Investments
Sofinnova Investments investment in Series B - NuCana
Scottish Enterprise
Scottish Enterprise investment in Series B - NuCana
Morningside Ventures
Morningside Ventures investment in Series B - NuCana
Sofinnova Partners
Sofinnova Partners investment in Series B - NuCana
Alida Capital International
Alida Capital International investment in Series A - NuCana
Morningside Ventures
Morningside Ventures investment in Series A - NuCana
Sofinnova Partners
Sofinnova Partners investment in Series A - NuCana
Scottish Investment Bank
Scottish Investment Bank investment in Series A - NuCana
Official Site Inspections
http://www.nucana.com Semrush global rank: 6.82 M Semrush visits lastest month: 760
- Host name: 64.98.135.33
- IP address: 64.98.135.33
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "NuCana"
NuCana plc - ProTide technology to transform some of the most …
We are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer. Utilizing our proprietary phosphoramidate technology we …See details»
NuCana plc - ProTide technology to transform some of …
Our name "NuCana" is derived from "New Cancer Agents”. It represents our goal of inventing, developing and commercializing truly novel, transformational medicines. Hugh is founder and Chief Executive Officer of NuCana with over …See details»
NuCana Plc
NuCana is focused on significantly improving treatment outcomes for patients with cancer. Our ProTides are designed to overcome the key cancer resistance mechnanisms associated with …See details»
NuCana Plc
"NuCana" is derived from "New Cancer Agents” and “Nucleotide Analogs”. It represents our goal of inventing, developing and commercializing truly novel, transformational medicines, as well as the proprietary medicinal chemistry …See details»
NuCana plc - AnnualReports.com
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying their ProTide …See details»
NuCana Company Profile 2024: Stock Performance & Earnings
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is …See details»
NuCana plc - LinkedIn
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry technology to...See details»
NuCana - Biotech Careers
Nucana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying phosphoramidate chemistry …See details»
NUCANA PLC Company Profile | EDINBURGH, United Kingdom
Find company research, competitor information, contact details & financial data for NUCANA PLC of EDINBURGH. Get the latest business insights from Dun & Bradstreet.See details»
Company NuCana plc - MarketScreener.com
NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatment outcomes for patients with cancer by applying its ProTide …See details»
NuCana plc - ProTide technology to transform some of …
We are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer. Utilizing our proprietary phosphoramidate technology we are developing more effective and safer anti …See details»
NuCana plc (NCNA) Company Profile & Overview - Stock Analysis
Nov 21, 2024 · NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to …See details»
NuCana CEO and Key Executive Team | Craft.co
NuCana's Founder, CEO & Board Member is Hugh Griffith. Other executives include Don Munoz, Chief Financial Officer; Jeffrey Bloss, Chief Medical Officer and 12 others. See the full …See details»
NuCana Reports Fourth Quarter and Year Ended 2021 Financial …
Apr 27, 2022 · NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our ProTide technology to …See details»
NuCana Reports Third Quarter 2022 Financial Results and Provides ...
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our ProTide technology to transform …See details»
NuCana Company Profile - Office Locations, Competitors, Revenue …
Oct 4, 2024 · NuCana is a clinical-stage biopharmaceutical company developing new medicines to treat cancer. It offers ProTide technology, specific combinations of aryl, ester, and amino …See details»
NuCana Reports Fourth Quarter and Year-End 2020 Financial …
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our ProTide technology to transform …See details»
NuCana Reports Second Quarter 2024 Financial Results and …
Aug 15, 2024 · NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our ProTide technology to …See details»
PRESS RELEASE - NuCana
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our ProTide technology to transform …See details»
NuCana: An Intriguing 'Sum Of The Parts' Story - Seeking Alpha
Sep 22, 2022 · NuCana plc shares currently trade just under $1.50 a share and sport an approximate market cap of $75 million. The company is using its proprietary ProTides …See details»